152 related articles for article (PubMed ID: 35066967)
1. Secretory type II cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells.
Pang J; Li G; Qian H; Wu Y; Chen Y
Cell Biol Int; 2022 May; 46(5):747-754. PubMed ID: 35066967
[TBL] [Abstract][Full Text] [Related]
2. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.
Chan CM; Chang HH; Wang VC; Huang CL; Hung CF
PLoS One; 2013; 8(2):e56819. PubMed ID: 23457620
[TBL] [Abstract][Full Text] [Related]
4. Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells.
Jiang L; Chen Y; Sang J; Li Y; Lan T; Wang Y; Tao Y; Qian H
Biomed Rep; 2013 May; 1(3):399-404. PubMed ID: 24648957
[TBL] [Abstract][Full Text] [Related]
5. PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.
Wu Y; Yao X; Zhu M; Qian H; Jiang L; Lan T; Wu M; Pang J; Chen Y
Oncotarget; 2016 Jun; 7(23):34190-200. PubMed ID: 27147579
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of platelet-derived growth factor receptor-β signaling mediated by integrin-associated MFG-E8.
Motegi S; Garfield S; Feng X; Sárdy M; Udey MC
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2653-64. PubMed ID: 21868707
[TBL] [Abstract][Full Text] [Related]
7. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
[TBL] [Abstract][Full Text] [Related]
8. PDGF-BB/PDGFRβ induces tumour angiogenesis via enhancing PKM2 mediated by the PI3K/AKT pathway in Wilms' tumour.
Sang BT; Wang CD; Liu X; Guo JQ; Lai JY; Wu XM
Med Oncol; 2023 Jul; 40(8):240. PubMed ID: 37442847
[TBL] [Abstract][Full Text] [Related]
9. PDGF-BB/PDGFRβ promotes epithelial-mesenchymal transition by affecting PI3K/AKT/mTOR-driven aerobic glycolysis in Wilms' tumor G401 cells.
Guo JQ; Wang CD; Tang HY; Sang BT; Liu X; Yi FP; Wu XM
Cell Biol Int; 2022 Jun; 46(6):907-921. PubMed ID: 35165984
[TBL] [Abstract][Full Text] [Related]
10. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
Wu Y; Chen Y; Qu R; Lan T; Sang J
Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
[TBL] [Abstract][Full Text] [Related]
11. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells.
Wang Y; Chen Y; Wu M; Lan T; Wu Y; Li Y; Qian H
Oncol Lett; 2015 Jul; 10(1):502-508. PubMed ID: 26171059
[TBL] [Abstract][Full Text] [Related]
12. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L
PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability.
Porsch H; Mehić M; Olofsson B; Heldin P; Heldin CH
J Biol Chem; 2014 Jul; 289(28):19747-57. PubMed ID: 24860093
[TBL] [Abstract][Full Text] [Related]
14. Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells.
Sang J; Chen Y; Jiang L; Tao Y; Wu Y; Wang Y; Li Y; Lan T; Shao G
Mol Med Rep; 2012 Nov; 6(5):1190-4. PubMed ID: 22940826
[TBL] [Abstract][Full Text] [Related]
15. Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.
Wu M; Chen Y; Jiang L; Li Y; Lan T; Wang Y; Qian H
Oncol Lett; 2013 Dec; 6(6):1723-1728. PubMed ID: 24273605
[TBL] [Abstract][Full Text] [Related]
16. Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal.
Gharibi B; Ghuman MS; Hughes FJ
J Cell Mol Med; 2012 Nov; 16(11):2789-801. PubMed ID: 22805337
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between soluble PDGF-BB and PDGFRβ promotes astrocytic activation and synaptic recovery in the hippocampus after subarachnoid hemorrhage.
Zhou X; Wu Q; Lu Y; Zhang X; Lv S; Shao J; Zhou Y; Chen J; Hou L; Huang C; Zhang X
FASEB J; 2019 Aug; 33(8):9588-9601. PubMed ID: 31162947
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin preparations promote PDGF-BB secretion to repair LPS-induced endothelial injury through the PDGFRβ/PI3K/Akt/IQGAP1 signalling pathway.
Zheng X; Zhang W; Wang Z
J Cell Mol Med; 2019 Dec; 23(12):8314-8327. PubMed ID: 31576676
[TBL] [Abstract][Full Text] [Related]
19. Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts.
Chen W; Yang X; Sun J; Chen Y; Zhao W; He C; An H; Pang J; Xu W; Wen B; Sun H; He S
J Ethnopharmacol; 2023 Jan; 301():115825. PubMed ID: 36240978
[TBL] [Abstract][Full Text] [Related]
20. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H
Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
